Guarantee Balances for Debt of Unconsolidated Subsidiaries
First written in FY2022-Q3. 8 of 12 entries say "Mitigated", first in FY2022. Latest entry: FY2026-H1.
The whole theme swung hardest in 2026: 6 of 28 companies on the "Worse" side.
27 other companies' latest entry also says "Mitigated".
- FY2026-H1MitigatedAnnual report
「石川医療器 Co., Ltd. 14,137 ¥ thousand 4,447 ¥ thousand」
Guarantees of trade payables for 石川医療器, an unconsolidated subsidiary, decreased from ¥14.137 million at the end of the previous fiscal year to ¥4.447 million at the end of the current interim period. - FY2025-H1MitigatedAnnual report
「石川医療器 Co., Ltd. 439 ¥ thousand 687 ¥ thousand」
Guarantees of trade payables to unconsolidated subsidiaries amounted to ¥439 thousand at the end of the previous fiscal year and ¥687 thousand at the end of the current interim period. Guarantees of borrowings for other unconsolidated subsidiaries that had previously been disclosed are not listed. - FY2024MitigatedAnnual report
「Total 432,644 ¥ thousand 99,930 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries decreased from ¥432.644 million at the end of the previous fiscal year to ¥99.93 million. - FY2024-Q3MitigatedAnnual report
「Total 432,644 ¥ thousand 304,920 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries decreased from ¥432.644 million at the end of the previous fiscal year to ¥304.92 million at the end of the third quarter. - FY2024-Q2MitigatedAnnual report
「Total 432,644 ¥ thousand 291,771 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries decreased from ¥432.644 million at the end of the previous fiscal year to ¥291.771 million at the end of the second quarter. - FY2024-Q1MitigatedAnnual report
「Total 432,644 ¥ thousand 101,613 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries decreased from ¥432.644 million at the end of the previous fiscal year to ¥101.613 million at the end of the first quarter. - FY2023WorsenedAnnual report
「Total 117,128 ¥ thousand 432,644 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries increased from ¥117.128 million at the end of the previous fiscal year to ¥432.644 million. - FY2023-Q3WorsenedAnnual report
「Guarantees have been provided for trade payables and borrowings from financial institutions of the following unconsolidated subsidiaries. Previous fiscal year (30 June 2022) Current third-quarter consolidated accounting period (31 March 2023) Total 117,128 ¥ thousand 485,820 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries increased from ¥117.128 million at the end of the previous fiscal year to ¥485.82 million at the end of the third quarter. - FY2023-Q2MitigatedAnnual report
「Guarantees have been provided for trade payables and borrowings from financial institutions of the following unconsolidated subsidiaries. Previous fiscal year (30 June 2022) Current second-quarter consolidated accounting period (31 December 2022) Total 117,128 ¥ thousand 110,341 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries decreased from ¥117.128 million at the end of the previous fiscal year to ¥110.341 million at the end of the second quarter. - FY2023-Q1WorsenedAnnual report
「Guarantees have been provided for trade payables and borrowings from financial institutions of the following unconsolidated subsidiaries. 石川医療器 Co., Ltd. 519 ¥ thousand 3,778 ¥ thousand メディカルバイオサイエンス Co., Ltd. 116,608 ¥ thousand 121,672 ¥ thousand Total 117,128 ¥ thousand 125,451 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries increased from ¥117.128 million at the end of the previous fiscal year to ¥125.451 million at the end of the first quarter. - FY2022MitigatedAnnual report
「Guarantees have been provided for trade payables and borrowings from financial institutions of the following unconsolidated subsidiaries. 石川医療器 Co., Ltd. 519 ¥ thousand メディカルバイオサイエンス Co., Ltd. 116,608 ¥ thousand Total 117,128 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries amounted to ¥117.128 million, down from ¥415.289 million at the end of the third quarter. - FY2022-Q3First statedAnnual report
「Guarantees have been provided for trade payables and borrowings from financial institutions of the following unconsolidated subsidiaries. 石川医療器 Co., Ltd. 225 ¥ thousand 4,351 ¥ thousand メディカルバイオサイエンス Co., Ltd. 132,724 ¥ thousand 410,937 ¥ thousand Total 132,949 ¥ thousand 415,289 ¥ thousand」
Guarantees of liabilities to unconsolidated subsidiaries were recorded at ¥415.289 million, up from ¥132.949 million at the end of the previous fiscal year.